Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
Phase 2
Recruiting
- Conditions
- Breast Cancer Metastatic
- Interventions
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 145
- Registration Number
- NCT05759572
- Locations
- 🇨🇳
Breast cancer institute of Fudan University Cancer Hospital, Shanghai, Shanghai, China
PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer
Phase 2
Recruiting
- Conditions
- Breast Cancer Metastatic
- Interventions
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 200
- Registration Number
- NCT05759546
- Locations
- 🇨🇳
Breast cancer institute of Fudan University Cancer Hospital, Shanghai, Shanghai, China
A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
Not Applicable
Recruiting
- Conditions
- Metastatic Esophageal Squamous Cell Carcinoma
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT05760391
- Locations
- 🇨🇳
Fudan University Shanghai cancer center, Shanghai, China
Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma
Phase 1
Not yet recruiting
- Conditions
- Ovarian Clear Cell Carcinoma
- Interventions
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 20
- Registration Number
- NCT05759312
Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study
Phase 2
Recruiting
- Conditions
- Colorectal Liver Metastasis
- Interventions
- Combination Product: HAIC-FOLFOX combined with Sintilimab and Regorafenib
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 44
- Registration Number
- NCT05753163
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
FUSCC Refractory TNBC Platform Study (FUTURE2.0)
Phase 2
Recruiting
- Conditions
- Triple-negative Breast Cancer
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT05749588
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2023-02-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 80
- Registration Number
- NCT05744518
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)
Phase 2
Not yet recruiting
- Conditions
- Locally Advanced Colon Cancer
- Interventions
- First Posted Date
- 2023-02-17
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT05732493
The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.
Phase 2
Not yet recruiting
- Conditions
- Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 29
- Registration Number
- NCT05732129
- Locations
- 🇨🇳
Department of Colorectal Surgery Fudan University Shanghai Caner Center, Shanghai, Shanghai, China
Cohort of Twin Pregnancy and the Offspring
Recruiting
- Conditions
- Twin Pregnancy
- Interventions
- Other: All pregnant women with a twin pregnancy and the offspring
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1000
- Registration Number
- NCT05727085
- Locations
- 🇨🇳
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath